Top 4 Companies Ruling the Global Atrophic Scar Treatment Market, Aided by Rising Skin-Consciousness

The global atrophic scar treatment market is expected to grow at a CAGR of 4.3% in the forecast period of 2023-2028. As per the analysis by Expert Market Research, the market is expected to be driven by the growing prevalence of atrophic scars among adolescents.

The growing prevalence of atrophic scars, especially among adolescents, is propelling the market for atrophic scar treatment. With the increasing skin-consciousness, the demand for chemical peeling for accelerating the process of skin repair and effectively treating atrophic scarring is increasing. In chemical peeling solutions, mild chemicals like glycolic acid and phenol, among others, are used to decrease the appearance of atrophic scars.

There is a rising demand for soft-tissue fillers as a common treatment for atrophic scars. As fillers provide immediate results while effectively raising or levelling scars, their demand is significantly increasing. Such fillers also decrease scarring appearances while improving skin volume, which is further aiding the market for atrophic scar treatment.

The surging availability of diverse types of fillers is favouring the market growth. Several key players in the market are launching innovative injectables to bolster skin regeneration and soft tissue augmentation. For instance, in February 2020, Bioscience GmbH launched Hyaprof, a new injectable line, to correct facial atrophic scars, fine forehead lines, and residual rhytids, among others.

Abrasive laser is considered an effective treatment method for atrophic scars, which is significantly boosting its popularity. The growing cost-effectiveness and accessibility of laser treatment to correct atrophic scars are further propelling the market growth.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Top 4 Atrophic Scar Treatment Companies in the World:

Merz Pharmaceuticals GmbH

Merz is a prominent pharmaceutical company that focuses on neurotoxin therapy, aesthetics, prescription medicines, and consumer health and beauty products. The company aims to offer aesthetics and neuroscience clinicians innovative solutions to meet the diverse requirements of patients. Through its Merz Corporate Venture Capital Initiative, it invests in innovative companies to link its expertise with advanced technologies and ideas.

Candela Medical

Candela is a medical aesthetic device company that provides energy-based solutions to physicians. Its solutions are used in various medical aesthetic applications like wrinkle reduction, scar revision, and pigmented lesions treatment, among others. Its products are marketed and sold across 100 countries. In January 2021, the company announced the availability of its Frax Pro™ system.

Lumenis Ltd.

Lumenis is a global company that offers innovative minimally invasive clinical solutions for the aesthetics and ophthalmology markets. It develops and commercialises advanced energy-based technologies such as laser, radio-frequency (RF), and intense pulsed light (IPL), among others. It aims to provide cutting-edge solutions to medical professionals to improve the well-being and health of patients.

Suneva Medical, Inc.

Suneva Medical, Inc. is a company that is engaged in the development, commercialisation, and manufacturing of branded products for the regenerative aesthetics sector. The company offers a portfolio of diverse products to deliver solutions for boosting the body’s restorative capacity and minimising the negative impact of ageing processes. Its expansive portfolio offers innovative, safe, and effective technologies to providers to address diverse consumer demands.